D17

The dosage of Lactic Acid, Dl- is highly individualized and depends on the specific condition being treated and the concentration of the product prescribed.

• For Hyperkeratotic Conditions (e.g., Ichthyosis, Xerosis): The standard adult recommendation is the application of a 12% Lactic Acid cream or lotion to the affected areas twice daily. Patients should be advised to rub the medication in thoroughly until it is completely absorbed.
• For General Dry Skin: Lower concentrations (5-10%) may be used once or twice daily as needed.
• Systemic Use (Sodium Lactate): Dosing is calculated based on the patient's acid-base balance, body weight, and serum electrolyte levels. This is strictly managed in a hospital setting.

Lactic Acid, Dl- must be used with caution in pediatric populations due to their higher surface-area-to-body-weight ratio, which increases the risk of systemic absorption.

• Children 2 years and older: Dosage is generally similar to adults (application twice daily), but healthcare providers often recommend starting with a lower concentration or once-daily application to assess skin tolerance.
• Infants and Children under 2 years: Safety and efficacy have not been established for this age group. Use is typically avoided unless specifically directed by a pediatric dermatologist, as the infant skin barrier is more permeable.

Renal Impairment

While topical Lactic Acid, Dl- does not usually require dose adjustments for patients with kidney disease, systemic administration of lactate-containing fluids requires extreme caution. In patients with severe renal failure, the ability to excrete the metabolic byproducts of lactate may be compromised, potentially leading to fluid overload or electrolyte imbalances.

Hepatic Impairment

Since the liver is the primary site for the metabolism of lactate into bicarbonate, patients with significant hepatic dysfunction (e.g., cirrhosis) may not process lactate efficiently. This can lead to an accumulation of lactate in the blood. Topical use is generally safe, but systemic use should be carefully monitored.

Elderly Patients

Elderly patients often have thinner, more fragile skin. Healthcare providers may suggest less frequent application (e.g., once daily) to prevent excessive irritation or 'over-exfoliation.'

For topical formulations, proper application technique is vital for both safety and efficacy:

1. 1Cleanse the Area: Wash the affected skin with a mild, soap-free cleanser and pat dry before application.
2. 2Apply Sparingly: Use only enough medication to cover the affected area. More is not necessarily better and can increase the risk of irritation.
3. 3Avoid Sensitive Areas: Do not apply Lactic Acid, Dl- to the eyes, lips, mucous membranes, or areas of broken or severely inflamed skin.
4. 4Sun Protection: Because Lactic Acid is an alpha-hydroxy acid, it increases the skin's sensitivity to UV radiation. Always apply a broad-spectrum sunscreen (SPF 30 or higher) to treated areas that are exposed to the sun.
5. 5Storage: Store the medication at room temperature (20°C to 25°C / 68°F to 77°F). Keep the container tightly closed and away from excessive heat.

If you miss a dose of Lactic Acid, Dl-, apply it as soon as you remember. However, if it is almost time for your next scheduled application, skip the missed dose and return to your regular dosing schedule. Do not 'double up' the amount applied to make up for a missed dose, as this significantly increases the risk of skin irritation.

Topical overdose typically manifests as severe skin redness, burning, peeling, or blistering. If this occurs, wash the area thoroughly with cool water and discontinue use until you consult your healthcare provider.

In the rare event of accidental ingestion, symptoms may include gastrointestinal irritation, nausea, or metabolic disturbances. Seek emergency medical attention or contact a Poison Control Center immediately.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop using the medication without first consulting your medical team.

Most patients using Lactic Acid, Dl- will experience mild localized reactions, particularly during the first few weeks of treatment as the skin adjusts to the acidic pH. These include:

• Transient Stinging: A mild pricking or stinging sensation immediately after application. This typically lasts for 5 to 10 minutes.
• Burning Sensation: A feeling of warmth or mild burning on the treated area.
• Erythema (Redness): Mild pinkness or redness of the skin.
• Peeling: As the medication works to exfoliate the skin, visible flaking or peeling may occur. This is often a sign the medication is effective but should not be painful.

• Persistent Irritation: Redness or burning that does not resolve within an hour of application.
• Dryness: Paradoxically, if used too frequently, it can over-strip the skin's natural oils, leading to localized dryness.
• Hyper-pigmentation or Hypo-pigmentation: Temporary changes in skin color, particularly in individuals with darker skin tones, often as a result of localized irritation.

• Contact Dermatitis: An allergic-type reaction characterized by an itchy, blistering rash at the site of application.
• Severe Photosensitivity: Extreme sensitivity to sunlight resulting in rapid sunburn even with minimal exposure.
• Systemic Lactate Accumulation: Extremely rare with topical use; only documented in cases of extensive application to severely damaged skin in infants.

While Lactic Acid, Dl- is generally safe for topical use, certain reactions require immediate clinical intervention.

> Warning: Stop taking Lactic Acid, Dl- and call your doctor immediately if you experience any of these:

1. 1Severe Blistering: The appearance of large blisters or 'weeping' skin at the application site, which may indicate a chemical burn or severe allergic reaction.
2. 2Angioedema: Swelling of the face, lips, tongue, or throat, which can indicate a systemic allergic response.
3. 3Difficulty Breathing: Any signs of wheezing or shortness of breath after application.
4. 4Widespread Rash: A rash that spreads beyond the area of application, accompanied by fever or malaise.
5. 5Severe Dizziness: Feeling lightheaded or fainting, which could suggest a rare systemic reaction.

Prolonged use of high-concentration Lactic Acid, Dl- can lead to 'thinning' of the stratum corneum. While this is the intended effect for treating hyperkeratosis, it may make the skin permanently more susceptible to environmental damage and UV radiation. Chronic irritation may also lead to the development of telangiectasias (visible small blood vessels) in sensitive individuals. It is essential to have your skin monitored periodically by a healthcare provider during long-term therapy.

No FDA black box warnings currently exist for Lactic Acid, Dl- topical preparations. However, the FDA does require a specific 'Sunburn Alert' on the labeling of all cosmetic and drug products containing alpha-hydroxy acids (AHAs). This alert warns consumers that the product may increase skin sensitivity to the sun and particularly the possibility of sunburn.

Report any unusual symptoms or persistent skin changes to your healthcare provider. Your doctor may recommend adjusting the frequency of use or switching to a different formulation if side effects become bothersome.

Lactic Acid, Dl- is a potent pharmacological agent and must be used with an understanding of its chemical properties. It is intended for external use only. Patients must ensure that the medication does not come into contact with the eyes, as it can cause severe corneal irritation or chemical burns. If accidental eye contact occurs, flush immediately with large amounts of water for at least 15 minutes and seek ophthalmologic evaluation.

As of 2026, there are no FDA black box warnings for Lactic Acid, Dl-. It is generally recognized as safe (GRAS) when used as directed for its approved indications.

• Allergic Reactions / Anaphylaxis Risk: Although rare, hypersensitivity to lactic acid or any of the excipients in the cream/lotion (such as parabens or cetyl alcohol) can occur. Patients with a history of multiple skin allergies should perform a 'patch test' on a small area of skin for 48 hours before widespread use.
• Sun Exposure: The most significant precaution for Lactic Acid, Dl- is the increased risk of UV damage. The exfoliation of the outer skin layer removes a natural barrier against the sun. This risk persists for up to one week after discontinuing the product.
• Skin Barrier Compromise: Do not apply Lactic Acid, Dl- to skin that is actively infected, oozing, or has open wounds. The acidic nature of the product can cause intense pain and may delay wound healing.
• Secondary Infections: If the treated skin becomes excessively irritated, it may become a portal for bacterial or fungal infections. Monitor for signs of pus, increased swelling, or spreading warmth.

For standard topical use, routine laboratory monitoring (such as blood counts or liver enzymes) is not typically required. However, clinical monitoring is essential:

• Dermatological Evaluation: A baseline skin exam followed by periodic checks to ensure the condition is improving and that no precancerous lesions are being masked by the treatment.
• Electrolyte Monitoring: Only required for patients receiving systemic (IV) sodium lactate, particularly monitoring serum potassium and bicarbonate levels.

Topical application of Lactic Acid, Dl- does not impair the ability to drive or operate heavy machinery. There are no known sedative or cognitive effects associated with this medication.

There is no direct pharmacological interaction between topical Lactic Acid, Dl- and alcohol consumption. However, excessive alcohol use can dehydrate the skin, potentially counteracting the moisturizing benefits of the medication.

Lactic Acid, Dl- does not require a tapering period. However, if the medication is stopped abruptly, the hyperkeratotic condition (such as dry scales) may return within a few weeks. If you experience a significant 'rebound' of symptoms, consult your healthcare provider about a long-term maintenance schedule.

> Important: Discuss all your medical conditions, especially any history of skin cancer or eczema, with your healthcare provider before starting Lactic Acid, Dl-.

There are no absolute systemic drug-drug contraindications for topical Lactic Acid, Dl-. However, in a dermatological context, it should not be used simultaneously with other potent chemical exfoliants or 'peels' (such as high-concentration glycolic acid or TCA peels) unless under the direct supervision of a dermatologist. Combining these can lead to severe chemical burns and permanent scarring.

• Topical Retinoids (e.g., Tretinoin, Adapalene, Tazarotene): Using Lactic Acid, Dl- alongside retinoids can significantly increase the risk of severe skin irritation and barrier breakdown. Both classes of drugs increase cell turnover. If used together, healthcare providers often recommend using Lactic Acid in the morning and the retinoid at night, or using them on alternating days.
• Benzoyl Peroxide: This common acne treatment can be very drying. When used with Lactic Acid, Dl-, the cumulative drying effect can lead to cracked, painful skin.

• Salicylic Acid: As a beta-hydroxy acid (BHA), salicylic acid works differently than lactic acid. While they are sometimes combined in professional formulations, using separate products containing these acids can lead to over-exfoliation.
• Vitamin C (Ascorbic Acid): Topical Vitamin C is often formulated at a low pH. Layering it with Lactic Acid can alter the pH balance of both products, potentially reducing the efficacy of the Vitamin C and increasing the irritation potential of the Lactic Acid.

There are no known food interactions with topical Lactic Acid, Dl-. Diet does not affect the absorption or metabolism of the medication when applied to the skin.

• St. John's Wort: This supplement is known to increase photosensitivity. Using it while applying Lactic Acid, Dl- may further heighten the risk of severe sunburn.
• Other Supplements: There are no documented interactions with common supplements like fish oil, multivitamins, or herbal extracts when Lactic Acid is used topically.

• Blood Lactate Levels: In extremely rare cases of massive topical over-application (especially in infants), systemic absorption could theoretically interfere with blood lactate measurements, which are used to assess tissue perfusion in critical care settings.
• Urinary pH: Systemic absorption of large amounts of lactate can slightly increase urinary pH (making it more alkaline).

For each major interaction, the mechanism is typically a pharmacodynamic interaction, where the combined effect of two skin-active agents exceeds the skin's tolerance threshold. Management strategies involve 'contact time' adjustments (washing one product off before applying the next) or 'moisture sandwiching' (applying a plain emollient between active layers).

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter skincare products.

Lactic Acid, Dl- must NEVER be used in the following circumstances:

1. 1Hypersensitivity: Any known previous allergic reaction to Lactic Acid, Dl- or any component of the formulation (e.g., ammonium lactate, parabens, or specific emollients used in the base). The mechanism is an IgE-mediated or delayed-type hypersensitivity reaction.
2. 2Severely Denuded Skin: Application to skin where the epidermis is missing (e.g., second or third-degree burns) is contraindicated. The acidic nature of the drug can cause deep tissue damage and systemic absorption levels that are unsafe.
3. 3Active Malignancy in the Treatment Area: Do not apply to areas with known or suspected skin cancer (e.g., basal cell carcinoma, melanoma) until cleared by an oncologist, as the increased cell turnover could theoretically interfere with lesion assessment.

Conditions requiring careful risk-benefit analysis include:

• Eczema (Atopic Dermatitis): Patients with eczema have a compromised skin barrier. Lactic acid may cause intense stinging and trigger a flare-up. Use should be limited to non-inflamed areas.
• Rosacea: The facial skin of rosacea patients is hyper-reactive to acids. Lactic Acid, Dl- should be used with extreme caution on the face.
• Pregnancy: While systemic absorption is low, it should only be used if clearly needed (see Special Populations).

Patients who are sensitive to other alpha-hydroxy acids (such as glycolic acid, citric acid, or malic acid) are highly likely to experience similar sensitivity to Lactic Acid, Dl-. A history of 'acid sensitivity' in cosmetic products should be reported to the healthcare provider.

> Important: Your healthcare provider will evaluate your complete medical history and perform a skin assessment before prescribing Lactic Acid, Dl-.

FDA Pregnancy Category C.

There are no adequate and well-controlled studies of Lactic Acid, Dl- in pregnant women. Animal reproduction studies have not been conducted. While topical absorption is relatively low, the physiological changes in pregnancy (such as increased skin vascularity) could theoretically increase systemic exposure. Lactic Acid, Dl- should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is generally recommended to avoid application to large surface areas for prolonged periods during the first trimester.

It is not known whether topically applied lactic acid is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Lactic Acid, Dl- is administered to a nursing woman. Crucially, the medication should not be applied to the breast or nipple area to prevent the nursing infant from direct oral ingestion or skin-to-skin contact with the drug.

Safety and effectiveness in pediatric patients under the age of 2 have not been established. In older children, Lactic Acid, Dl- should be used under close medical supervision. Children have a higher surface-area-to-mass ratio, making them more susceptible to systemic effects if the drug is absorbed. Healthcare providers typically recommend limited application areas and strict sun protection for pediatric patients.

Clinical studies of Lactic Acid, Dl- (as 12% ammonium lactate) did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, geriatric skin is often physiologically different—thinner and with reduced lipid content. This may lead to an increased incidence of irritation. Physicians may suggest a 'trial period' with once-daily application for elderly patients.

For topical use, no dosage adjustment is typically necessary. For systemic use (sodium lactate), the drug is contraindicated in severe renal failure because the resulting bicarbonate cannot be effectively regulated by the kidneys, leading to a risk of metabolic alkalosis.

In patients with severe liver disease, the conversion of lactate to bicarbonate is impaired. While topical use remains safe due to low systemic levels, these patients should be monitored for signs of localized irritation, and systemic lactate therapy should be avoided.

> Important: Special populations require individualized medical assessment to ensure the safest possible treatment plan.

Lactic Acid, Dl- is an alpha-hydroxy acid (AHA) with the chemical formula C3H6O3. Its primary mechanism of action is keratolytic. It acts as a chemical exfoliant by increasing the hydration of the skin and reducing the intercellular cohesion between corneocytes in the stratum corneum. Specifically, it interferes with the ionic bonds (calcium-dependent) that hold skin cells together. By sequestering calcium ions, it destabilizes the desmosomes, allowing the dead skin cells to shed more easily. Additionally, as a humectant, it contains hydroxyl groups that form hydrogen bonds with water, trapping moisture within the skin matrix.

The pharmacodynamic effect of Lactic Acid, Dl- is local and concentration-dependent.

• Onset: Increased skin hydration can be observed within 2-4 hours of the first application.
• Peak Effect: Significant reduction in skin scaling and thickness typically requires 2 to 4 weeks of continuous twice-daily use.
• Duration: The effects on the skin barrier persist for approximately 48-72 hours after the last application. There is no evidence of pharmacological tolerance; the drug remains effective as long as it is applied.

| Parameter | Value |

|---|---|

| Bioavailability | 5% - 12% (Topical) |

| Protein Binding | Negligible |

| Half-life | 15 - 30 minutes (Systemic) |

| Tmax | 1 - 3 hours (Topical absorption) |

| Metabolism | Hepatic (via LDH to Pyruvate) |

| Excretion | Exhaled as CO2; Renal (minor) |

• Molecular Formula: C3H6O3
• Molecular Weight: 90.08 g/mol
• Solubility: Highly soluble in water and ethanol.
• Structure: A carboxylic acid with a hydroxyl group on the adjacent carbon (alpha carbon). The Dl- form is a 50/50 racemic mixture of the D(-) and L(+) enantiomers.

Lactic Acid, Dl- is classified as a Keratolytic Agent and an Alpha-Hydroxy Acid (AHA). It is therapeutically related to glycolic acid and salicylic acid, though it is generally considered more hydrating and less irritating than glycolic acid at equivalent concentrations.